MAB

Fetch's Cutting-Edge Advertising Campaign Optimization Technology Validated with First Patent

Retrieved on: 
Wednesday, April 24, 2024

MADISON, Wis., April 24, 2024 /PRNewswire/ -- Fetch, America's Rewards App, today announced that the company has secured a patent for its BrandChoice Tech, its digital advertising technology that uses artificial intelligence and machine learning to automate campaign testing and optimization. Drawing on Fetch's unparalleled, real-time view of consumer purchase history, this now-patented technology accelerates and expands the platform's advertising personalization, recommendation and campaign optimization capabilities.

Key Points: 
  • Drawing on Fetch's unparalleled, real-time view of consumer purchase history, this now-patented technology accelerates and expands the platform's advertising personalization, recommendation and campaign optimization capabilities.
  • Fetch has secured a patent for its BrandChoice Tech – its AI and ML technology that optimizes advertising campaigns.
  • And right now, it's harder than ever to make these connections," said Wes Schroll, CEO and Founder of Fetch.
  • "There's enormous potential for applications of AI and ML in the advertising technology industry," said Wade Bruce, Chief Technology Officer at Fetch.

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board

Retrieved on: 
Thursday, March 14, 2024

Dr. Fezza joins the MAB as Nordic Pharma prepares to launch a novel therapy for Dry Eye Disease, LACRIFILL® Canalicular Gel.

Key Points: 
  • Dr. Fezza joins the MAB as Nordic Pharma prepares to launch a novel therapy for Dry Eye Disease, LACRIFILL® Canalicular Gel.
  • The FDA-cleared, cross-linked hyaluronic acid derivative LACRIFILL is intended to temporarily block tear drainage by the occlusion of the canalicular system.
  • “The entire U.S. Medical Advisory Board of Nordic Pharma is honored and delighted to welcome John Fezza, MD, a world class oculoplastic surgeon to our MAB,” said Eric Donnenfeld, MD, MAB Chair.
  • Nordic Pharma is committed to engaging ophthalmologists and optometrists in the early launch stages of LACRIFILL Canalicular Gel.

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair

Retrieved on: 
Monday, February 26, 2024

Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today that preeminent ophthalmologist Eric D. Donnenfeld, MD will Chair its U.S. Medical Advisory Board (MAB) which includes Richard Lindstrom, MD (Minnesota), Vance Thompson, MD (South Dakota), Preeya Gupta, MD (North Carolina), Paul Karpecki, OD (Kentucky), Lisa Nijm, MD, JD (Illinois), and Selina McGee, OD (Oklahoma).

Key Points: 
  • Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today that preeminent ophthalmologist Eric D. Donnenfeld, MD will Chair its U.S. Medical Advisory Board (MAB) which includes Richard Lindstrom, MD (Minnesota), Vance Thompson, MD (South Dakota), Preeya Gupta, MD (North Carolina), Paul Karpecki, OD (Kentucky), Lisa Nijm, MD, JD (Illinois), and Selina McGee, OD (Oklahoma).
  • Dr. Donnenfeld joins the MAB as Nordic Pharma prepares to launch a novel therapy for Dry Eye Disease, LACRIFILL® canalicular gel.
  • The FDA-cleared hyaluronic acid derivative LACRIFILL is intended to temporarily block tear drainage by the occlusion of the canalicular system.
  • “Nordic Pharma continues to build a world class group of key opinion leaders with Eric agreeing to lead our esteemed MAB in the U.S. as we prepare to bring LACRIFILL to market.

RTX's Collins Aerospace to provide Malaysia Airlines with new avionics and systems support

Retrieved on: 
Wednesday, February 21, 2024

SINGAPORE, Feb. 21, 2024 /PRNewswire/ -- Malaysia Airlines Berhad (MAB) have signed an avionics hardware and support agreement for its fleet of 737-8 aircraft with Collins Aerospace, an RTX (NYSE: RTX) business, at the 2024 Singapore Air Show.

Key Points: 
  • Airline fleet to be enhanced with critical avionics systems, air data sensors and maintenance, repair and overhaul services
    SINGAPORE, Feb. 21, 2024 /PRNewswire/ -- Malaysia Airlines Berhad (MAB) have signed an avionics hardware and support agreement for its fleet of 737-8 aircraft with Collins Aerospace, an RTX (NYSE: RTX) business, at the 2024 Singapore Air Show.
  • Critical communications, navigation, surveillance systems and air data sensors will be provided and serviced by Collins' Dispatchsm solution – a comprehensive service plan covering maintenance, assets and logistical support.
  • MAB will have access to original equipment manufacturer-certified spares, repairs and service, while ensuring parts availability and expedited turnaround times at predictable costs.
  • "As the demand for travel continues to soar, our narrowbody fleet remains pivotal in supporting connectivity to key markets.

Government of Canada announces appointment of new Chair to Royal Canadian Mounted Police's Management Advisory Board

Retrieved on: 
Friday, December 22, 2023

OTTAWA, ON, Dec. 22, 2023 /CNW/ - Today, the Honourable Dominic LeBlanc, Minister of Public Safety, Democratic Institutions and Intergovernmental Affairs, announced the appointment of Professor Angela Campbell as Chairperson of the Royal Canadian Mounted Police (RCMP)'s Management Advisory Board (MAB).

Key Points: 
  • OTTAWA, ON, Dec. 22, 2023 /CNW/ - Today, the Honourable Dominic LeBlanc, Minister of Public Safety, Democratic Institutions and Intergovernmental Affairs, announced the appointment of Professor Angela Campbell as Chairperson of the Royal Canadian Mounted Police (RCMP)'s Management Advisory Board (MAB).
  • Mr. Coakeley will continue to provide perspective and guidance as he returns to his role as Vice-Chairperson.
  • - The Honourable Dominic LeBlanc, Minister of Public Safety, Democratic Institutions and Intergovernmental Affairs
    "Congratulations to Professor Campbell on her appointment to Chair of the Management Advisory Board.
  • It also provided advisory reports on the Cadet Training Program and on Indigenous recruitment efforts.

Air Lease Corporation Announces Delivery of First of 25 New Boeing 737-8 Aircraft to Malaysia Airlines Berhad

Retrieved on: 
Tuesday, November 21, 2023

Air Lease Corporation (NYSE: AL) announced today the first of 25 new Boeing 737-8 aircraft delivered to Malaysia Airlines Berhad from ALC’s order book with Boeing.

Key Points: 
  • Air Lease Corporation (NYSE: AL) announced today the first of 25 new Boeing 737-8 aircraft delivered to Malaysia Airlines Berhad from ALC’s order book with Boeing.
  • Featuring CFM LEAP 1B-27 engines, this new Boeing aircraft is the first 737-8 addition to Malaysia Airlines’ fleet.
  • “We are thrilled to announce ALC’s first of 25 new Boeing 737-8 aircraft delivered to Malaysia Airlines,” said Steven Udvar-Házy, Executive Chairman of Air Lease Corporation.
  • Malaysia Airlines is the national carrier of Malaysia, offering the best way to fly to, from and around Malaysia.

Michigan Association of Broadcasters to Welcome More Than 900 Attendees to Discuss and Explore Broadcast Careers at the 2nd Annual Great Lakes Broadcast and Sports Media Academy

Retrieved on: 
Thursday, October 26, 2023

DETROIT, Oct. 26, 2023 /PRNewswire/ -- The Michigan Association of Broadcasters is hosting its 2nd annual Great Lakes Broadcast and Sports Media Academy at Ford Field on Thursday, November 2nd.

Key Points: 
  • DETROIT, Oct. 26, 2023 /PRNewswire/ -- The Michigan Association of Broadcasters is hosting its 2nd annual Great Lakes Broadcast and Sports Media Academy at Ford Field on Thursday, November 2nd.
  • More than 900 attendees from seven states are registered to attend the event including students from more than 50 schools from across Michigan.
  • Full details on the Great Lakes Broadcast and Sports Media Academy are available here .
  • The Academy builds on the recent launch of the MAB's "Be There" campaign to recruit new broadcasters to the industry.

SciTech Development Announces The Formation of a Distinguished Medical Advisory Board With Top Oncology Specialists

Retrieved on: 
Thursday, October 26, 2023

GROSSE POINTE FARMS, Mich., Oct. 26, 2023 /PRNewswire/ -- SciTech Development, LLC, today announced the formation of a distinguished and independent medical advisory board (MAB) comprised of key opinion leaders and world-renowned experts in T-Cell Lymphomas and hematological malignancies.

Key Points: 
  • GROSSE POINTE FARMS, Mich., Oct. 26, 2023 /PRNewswire/ -- SciTech Development, LLC, today announced the formation of a distinguished and independent medical advisory board (MAB) comprised of key opinion leaders and world-renowned experts in T-Cell Lymphomas and hematological malignancies.
  • The board will provide strategic and clinical advice for SciTech's outreach and education initiatives within the oncology community.
  • The three medical advisors appointed to the board are Madeleine Duvic, M.D., Larisa Geskin, M.D., and Ajay Gopal, M.D.
  • Madeleine Duvic, MD – "The development of ST-100 is exciting because this new drug holds the promise of improved bioavailability, leading to increased efficacy with low toxicity."

Leukemia Research Foundation Awards $2.4M in Research Grants

Retrieved on: 
Friday, September 29, 2023

NORTHFIELD, Ill., Sept. 29, 2023 /PRNewswire-PRWeb/ -- The Leukemia Research Foundation is pleased to award $2.4M in research grants through its 2023 New Investigator Research Grant Program.

Key Points: 
  • The Leukemia Research Foundation is pleased to award $2.4M in research grants through its 2023 New Investigator Research Grant Program.
  • NORTHFIELD, Ill., Sept. 29, 2023 /PRNewswire-PRWeb/ -- The Leukemia Research Foundation is pleased to award $2.4M in research grants through its 2023 New Investigator Research Grant Program.
  • The projects are highly innovative, with the potential to impact broad, essential areas of leukemia research.
  • Grantees named The 16 New Investigator Research Grant recipients for 2023 include:
    St Jude Children's Research Hospital, Inc.
    Peter Doherty Institute at the University of Melbourne, Australia
    To learn more about the Leukemia Research Foundations' research programs, and the deadlines for the 2024 grant program, visit leukemiarf.org/research

RhythmScience Announces Formation of Medical Advisory Board

Retrieved on: 
Thursday, August 31, 2023

SAN FRANCISCO, Aug. 31, 2023 /PRNewswire/ -- RhythmScience, a leader in cardiac data management and services, today announced the formation of its Medical Advisory Board (MAB).

Key Points: 
  • SAN FRANCISCO, Aug. 31, 2023 /PRNewswire/ -- RhythmScience, a leader in cardiac data management and services, today announced the formation of its Medical Advisory Board (MAB).
  • "We selected MAB members across a range of cardiology expertise, and we are excited to work with this esteemed group."
  • said Shawn Kumar, CEO of RhythmScience.
  • With their collective knowledge and expertise, we are confident in our ability to positively impact the future of cardiac care."